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Introduction
Juvenile idiopathic arthritis (JIA) is a multifactor chronic
inflammatory joints disease that is characterized by long
progressive course leading to the development of con-
tractures and loss of joint function. Prediction of the
likely outcomes and course of JIA is key approach of
treatment. Currently, there are only several laboratory
and radiological predictors of unfavorable prognosis of
JIA. Reduced sensitivity of cells to apoptosis is one the
possible mechanisms maintaining synovial inflammation
in JIA. Polymorphisms Arg72Pro 4exon, ins/del16bp
3intron, G/C 6intron can determine activity of the P53
protein - the key protein of intrinsic apoptosis pathway
(P.Dumont et al 2003; A.Sallivan et al, A.Ghosh et al
2004).
Objectives
We evaluated role of P53 gene polymorphisms in the
course and outcome of JIA.
Methods
Clinical, serological, x-ray manifestations, ultrasound and
MRI were analyzed in 126 children with JIA. 60 healthy
children without family history of any autoimmune disease
were controls. The P53 gene polymorphisms were
detected by PCR-RFLP.
Results
We haven’t revealed significant differences in genotypes
distributions of Arg72Pro ex4, ins/del16bp in3 and G/C
in6 between children with JIA and controls. We identified
significant difference of exon genotype Arg72Pro in girls
who still persistently in ≪active disease≫ more 2 years
compared with girls who achieved clinical remission
(Arg/Arg - 36,7% vs 83,3%, Arg/Pro - 51,1% vs 16,7%,
Pro/Pro - 12,2% vs 0%). 68% girls who achieved
≪inactive≫ oligoarthicular (OA) and polyarthicular (PA)
were with homozygous genotype Arg/Arg. Girls with Pro
allele genotypes (Arg/Pro, Pro/Pro) have the highest rates
of probability of the ≪active disease≫ for OA (OR =
158,3, p = 0,0001) and PA (OR = 32,8, p = 0,005) com-
pared with ERA (OR = 0,5, p = 0,8). Boys haven’t any
difference of exon genotype in JIA (p > 0,05, OR < 2,5).
We received no information about influence of intronic
polymorphisms on the JIA course. We haven’t any differ-
ence of polymorphisms P53 gene in children with joints
erosion and arthrosis.
Haplotypes */del-Arg/Arg-GG were significantly higher
in girls with clinical remission. Girls who still maintain an
≪active≫ OA and PA course had haplotypes */del-Arg/
Pro-G*, ins/del-Pro/Pro-GC, ins/ins-Pro/Pro-CC. Most
girls with ins/del-Pro/Pro-GC, ins/ins-Pro/Pro-CC were
with fibrous ankylosis.
Conclusion
We suggest that Pro allele genotypes of the exon poly-
morphism P53 gene contribute to persistence of
≪active disease≫ in girls with oligo-, polyarthritis.
Analysis Arg72Pro 4exon, ins/del16bp 3intron, G/C
6intron polymorphisms P53 gene can be used in a
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